Modified Glasgow Prognostic Score as a Predictor of Recurrence in Patients with High Grade Non-Muscle Invasive Bladder Cancer Undergoing Intravesical Bacillus Calmette-Guerin Immunotherapy.
Matteo FerroOctavian Sabin TătaruGennaro MusiGiuseppe LucarelliAbdal Rahman Abu FarhanFrancesco CantielloRocco DamianoRodolfo HurleRoberto ContieriGian Maria BusettoGiuseppe CarrieriLuigi CormioFrancesco Del GiudiceAlessandro SciarraSisto PerdonàMarco BorghesiCarlo TerroneEvelina La CivitaPierluigi BoveRiccardo AutorinoMatteo MutoNicolae CrisanMichele MarchioniLuigi SchipsFrancesco SoriaDaniela TerraccianoRocco PapaliaFelice CrocettoBiagio BaroneGiorgio Ivan RussoStefano LuzzagoGiuseppe Mario LudovicoMihai Dorin VartolomeiFrancesco Alessandro MistrettaVincenzo MironeOttavio de CobelliPublished in: Diagnostics (Basel, Switzerland) (2022)
mGPS may have the potential to predict recurrence in HG/G3 T1 NMIBC patients, but more prospective, with large cohorts, studies are needed to study the influence of systemic inflammatory markers in prediction of outcomes in NMIBC for a definitive conclusion.
Keyphrases